Molecular Pathways Underlying IBD-Associated Colorectal Neoplasia: Therapeutic Implications [RETRACTED]
Authors:
- 1 April 2011
- journal article
- retracted article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 106 (4) , 719-730
Abstract
Chronic inflammatory diseases, depending upon the duration and severity, are frequently associated with an increased risk of developing cancer. A classic paradigm is the enhanced risk of colorectal cancer (CRC) in patients with inflammatory bowel disease (IBD). Carcinogenesis is a multifactorial process that involves accumulation of genetic defects, protein modification, and cell–matrix interaction. In this review, we discuss aspects of chronic inflammation in IBD that influence the development of CRC and highlight the key molecular mediators involved in this process. Also, we identify potential targets that could facilitate earlier detection of dysplasia. The targeted manipulation of specific molecules or pathways could provide opportunities for the development of therapeutic and chemopreventive interventions, which may prove effective in arresting the progression of colitis-associated cancer (CAC), with clinical implications.Keywords
This publication has 94 references indexed in Scilit:
- Mesalamine Inhibits Epithelial β-Catenin Activation in Chronic Ulcerative ColitisGastroenterology, 2010
- A component of polysaccharide peptidoglycan complex on Lactobacillus induced an improvement of murine model of inflammatory bowel disease and colitis‐associated cancerImmunology, 2009
- Use of a novel genetic mouse model to investigate the role of folate in colitis-associated colon cancerThe Journal of Nutritional Biochemistry, 2009
- Mesalamine Suppresses the Expression of TC22, a Novel Tropomyosin Isoform Associated with Colonic NeoplasiaMolecular Pharmacology, 2009
- Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosisBiochemical Pharmacology, 2008
- Integrin-linked kinase regulates cell proliferation and tumour growth in murine colitis-associated carcinogenesisGut, 2008
- Increased susceptibility of chronic ulcerative colitis‐induced carcinoma development in DNA repair enzyme Ogg1 deficient miceMolecular Carcinogenesis, 2008
- Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal TumorsGastroenterology, 2007
- Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort StudyGastroenterology, 2007
- First clinical experience of orally active epidermal growth factor receptor inhibitor combined with simplified FOLFOX6 as first‐line treatment for metastatic colorectal cancerCancer, 2007